Skip to main content
  1. Market Insights
  2. Health
  3. Pharmaceuticals
  4. Vaccines

Other Vaccines - Pakistan

Pakistan
  • The Other Vaccines market in Pakistan is estimated to achieve a revenue of US$47.71m by 2024.
  • It is anticipated that the revenue will grow at an annual growth rate of 10.54% from 2024 to 2029, resulting in a market volume of US$78.73m by 2029.
  • When comparing this market globally, United States is expected to generate the highest revenue of US$24.73bn in 2024.
  • Pakistan is experiencing a growing demand for other vaccines as the government focuses on expanding its immunization program.

Definition:
This market covers all vaccines with the exception of COVID-19 vaccines. Vaccines against infectious diseases transmitted by viruses (e.g., hepatitis A and B) and bacteria (e.g., typhoid fever or meningococcus) are included.

Additional information:
Market values represent the revenues generated by manufacture prices paid to primary vendors, either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), companies (B2B), and governments (B2G).

Company examples: Pfizer, GlaxoSmithKline, Merck & Co, Sanofi

In-Scope

  • Vaccines against infectious diseases
  • Prophylactic and theurapeutic vaccines
  • Flu vaccines

Out-Of-Scope

  • Sera and gammaglobulins
  • Antivirals
  • Antibiotics
  • COVID-19 vaccines
Pharmaceuticals: market data & analysis - Cover

Market Insights report

Pharmaceuticals: market data & analysis

Study Details

    Revenue

    Notes: Data shown is using current exchange rates and reflects market impacts of the Russia-Ukraine war.

    Most recent update: Jun 2024

    Source: Statista Market Insights

    Notes: The chart “Comparable Estimates” shows the forecasted development of the selected market from different sources. Please see the additional information for methodology and publication date.

    Most recent update: Mar 2024

    Analyst Opinion

    The demand for vaccines in Pakistan has been increasing over the years due to the country's growing population and the government's efforts to improve access to healthcare. The Other Vaccines market in Pakistan has also been experiencing growth, driven by various factors.

    Customer preferences:
    Pakistan has a high incidence of infectious diseases, including hepatitis, typhoid fever, and polio. This has led to an increased demand for vaccines that can protect against these diseases. In addition, as the country's middle class grows, there is a greater awareness of the importance of preventive healthcare, including vaccination.

    Trends in the market:
    The Other Vaccines market in Pakistan has been growing steadily in recent years, with a focus on vaccines for infectious diseases. In particular, there has been an increasing demand for vaccines that protect against hepatitis B and C, as well as typhoid fever. There has also been a growing interest in travel vaccines, as more Pakistanis travel abroad for work and leisure.

    Local special circumstances:
    Pakistan faces unique challenges in ensuring access to vaccines for its population. These include a lack of infrastructure, particularly in rural areas, as well as a lack of awareness and education about the importance of vaccination. In addition, there have been concerns about the safety and efficacy of vaccines, which have led to some resistance to vaccination among certain segments of the population.

    Underlying macroeconomic factors:
    Pakistan's growing population and economy are driving demand for vaccines, particularly as the middle class expands. The government has also been investing in healthcare infrastructure and increasing access to vaccines, which has helped to boost demand. However, the country still faces challenges in ensuring that all segments of the population have access to vaccines, particularly in rural areas.

    Global Comparison

    Most recent update: Jun 2024

    Source: Statista Market Insights

    Methodology

    Data coverage:

    Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.

    Modeling approach / Market size:

    Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.

    Forecasts:

    In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.

    Additional notes:

    Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.

    Health

    Access more Market Insights on Health topics with our featured report

    Pharmaceuticals: market data & analysis - BackgroundPharmaceuticals: market data & analysis - Cover

    Key Market Indicators

    Notes: Based on data from IMF, World Bank, UN and Eurostat

    Most recent update: Sep 2024

    Source: Statista Market Insights

    Explore more high-quality data on related topic

    Global pharmaceutical industry - statistics & facts

    The pharmaceutical industry is responsible for the research, development, production, and distribution of medications. The market has experienced significant growth during the past two decades, and pharma revenues worldwide totaled 1.48 trillion U.S. dollars in 2022.
    More data on the topic

    Contact

    Get in touch with us. We are happy to help.